The protein arginine methyltransferase PRMT5 promotes D2-like dopamine receptor signaling

被引:15
|
作者
Likhite, Neah [1 ]
Jackson, Christopher A. [1 ]
Liang, Mao-Shih [2 ]
Krzyzanowski, Michelle C. [1 ]
Lei, Pedro [2 ]
Wood, Jordan F. [1 ]
Birkaya, Barbara [1 ]
Michaels, Kerry L. [1 ]
Andreadis, Stelios T. [2 ]
Clark, Stewart D. [3 ,4 ,5 ]
Yu, Michael C. [1 ]
Ferkey, Denise M. [1 ]
机构
[1] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA
[2] SUNY Buffalo, Bioengn Lab, Dept Chem & Biol Engn, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA
[4] SUNY Buffalo, Dept Psychol, Buffalo, NY 14214 USA
[5] SUNY Buffalo, Res Inst Addict, Buffalo, NY 14214 USA
基金
美国国家科学基金会;
关键词
CAENORHABDITIS-ELEGANS; C-ELEGANS; DORSAL STRIATUM; METHYLATION; LOCALIZATION; MECHANISMS; BEHAVIORS; BINDING; SENSITIVITY; ADDICTION;
D O I
10.1126/scisignal.aad0872
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methylation regulates diverse functions of eukaryotic cells, including gene expression, the DNA damage response, and circadian rhythms. We showed that arginine residues within the third intracellular loop of the human D2 dopamine receptor, which are conserved in the DOP-3 receptor in the nematode Caenorhabditis elegans, were methylated by protein arginine methyltransferase 5 (PRMT5). By mutating these arginine residues, we further showed that their methylation enhanced the D2 receptor-mediated inhibition of cyclic adenosine monophosphate (cAMP) signaling in cultured human embryonic kidney (HEK) 293T cells. Analysis of prmt-5-deficient worms indicated that methylation promoted the dopamine-mediated modulation of chemosensory and locomotory behaviors in C. elegans through the DOP-3 receptor. In addition to delineating a previously uncharacterized means of regulating GPCR (heterotrimeric guanine nucleotide-binding protein-coupled receptor) signaling, these findings may lead to the development of a new class of pharmacological therapies that modulate GPCR signaling by changing the methylation status of these key proteins.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The arginine methyltransferase PRMT5 promotes mucosal defense in the intestine
    Hernandez, Juan E.
    Llorente, Cristina
    Ma, Shengyun
    Miyamoto, Kiana T.
    Sinha, Saptarshi
    Steele, Scarlet
    Xiao, Zihui
    Lai, Ching-Jung
    Zuniga, Elina, I
    Ghosh, Pradipta
    Schnabl, Bernd
    Huang, Wendy Jia Men
    LIFE SCIENCE ALLIANCE, 2023, 6 (11)
  • [2] Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitors
    Lin, Hong
    Luengo, Juan, I
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1264 - 1269
  • [3] Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
    Palte, Rachel L.
    Schneider, Sebastian E.
    Altman, Michael D.
    Hayes, Robert P.
    Kawamura, Shuhei
    Lacey, Brian M.
    Mansueto, My Sam
    Reutershan, Michael
    Siliphaivanh, Phieng
    Sondey, Christopher
    Xu, Haiyan
    Xu, Zangwei
    Ye, Yingchun
    Machacek, Michelle R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1688 - 1693
  • [4] Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells
    Rasheed, Shayaan
    Bouley, Renee A.
    Yoder, Ryan J.
    Petreaca, Ruben C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [5] Protein arginine methyltransferase 5 (PRMT5) is a novel coactivator of constitutive androstane receptor (CAR)
    Kanno, Yuichiro
    Inajima, Jun
    Kato, Sayaka
    Matsumoto, Maika
    Tokumoto, Chikako
    Kure, Yuki
    Inouye, Yoshio
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (01) : 143 - 147
  • [6] EFFECT OF THE PROTEIN ARGININE METHYLTRANSFERASE PRMT5 INHIBITION IN GLIOMA STEM-LIKE CELLS
    Mittal, Sandeep
    Shaw, Vikram
    Piao, Yuji
    Park, Soon Young
    Sriram, Sai
    Dong, Jianwen
    Martinez-Ledesma, Emmanuel
    Henry, Verlene
    Ezhilarasan, Ravesanker
    Sulman, Erik
    Balasubramaniyan, Veerakumar
    de Groot, John
    NEURO-ONCOLOGY, 2018, 20 : 87 - 87
  • [7] Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) Inhibitors
    Lin, Hong
    Wang, Min
    Zhang, Yang W.
    Tong, Shuilong
    Leal, Raul A.
    Shetty, Rupa
    Vaddi, Kris
    Luengo, Juan I.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1033 - 1038
  • [8] Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders
    Shen, Yudao
    Gao, Guozhen
    Yu, Xufen
    Kim, Huensuk
    Wang, Li
    Xie, Ling
    Schwarz, Megan
    Chen, Xian
    Guccione, Ernesto
    Liu, Jing
    Bedford, Mark T.
    Jin, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9977 - 9989
  • [9] Aberrant miRNA expression and protein arginine methyltransferase 5 (PRMT5) in cancer: A review
    Sif, Said
    Al Alawneh, Majdi
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2025, 1872 (03):
  • [10] Protein arginine methyltransferase 5 (PRMT5) is a novel negative regulator of keratinocyte differentiation
    Kanade, S. R.
    Eckert, R. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S60 - S60